UPDATE : Wednesday, January 22, 2020
상단여백
Celltrion Group to build biopharmaceutical plant in China by Lee Han-soo 2020-01-21 18:00
Korea’s biopharma power shines at JP Morgan Healthcare meet by Jeong Sae-im 2020-01-17 15:20
HLB stocks fall in after-hours trading due to interview on rivoceranib by Jeong Sae-im 2020-01-16 15:46
Mundipharma to commercialize Samsung Bioepis’ biosimilar in Hong Kong, Taiwan by Lee Han-soo 2020-01-13 16:23
BioMarin seeks license for gene therapy to treat hemophilia by Kim Yun-mi 2020-01-06 16:44
라인
[New Year Special] Biotech rookies may shake up market cap rankings by Jeong Sae-im 2020-01-02 14:31
Humedix wins patent on new anti-aging material by Jeong Sae-im 2019-12-26 14:31
Vaxcell-Bio Therapeutics passes tech review for Kosdaq debut by Jeong Sae-im 2019-12-23 15:42
Samsung Bioepis’ Ontruzant 1st biosimilar to win WHO's PQ certification by Lee Han-soo 2019-12-20 16:29
Kolon appeals Invossa’s safety in pleading at court by Jeong Sae-im 2019-12-20 14:57
라인
4 firms to offer up to 56 direct-to-consumer genetic testing services by Jeong Sae-im 2019-12-19 16:40
Psomagen-Macrogen consortium acquires uBiome's patents, data by Lee Han-soo 2019-12-18 16:56
Venture capital investment in biomedical sector to hit record this year by Jeong Sae-im 2019-12-17 14:20
Celltrion secures 11 generic drugs to advance to US market by Lee Han-soo 2019-12-16 17:02
Helixmith to clarify why gene therapy study had data error by Jeong Sae-im 2019-12-13 15:13
라인
Yuhan to start phase-3 trial on lung cancer drug Lazertinib by Jeong Sae-im 2019-12-12 15:04
Aprogen, 1st Korean biotech firm to win unicorn status by Jeong Sae-im 2019-12-11 13:10
Samsung Bioepis to start P3 trial for Ontruzant in China by Lee Han-soo 2019-12-10 14:16
Samsung execs get jail term for destroying evidence by Jeong Sae-im 2019-12-10 11:43
Celltrion unveils long-term P3 trial results for Truxima in US by Lee Han-soo 2019-12-09 10:36
여백
여백
여백
Back to Top